Experiences of ANC Women with Distributing HIV Self-Testing Kits to Male Partners in Eswatini

Background The Botswana Tsepamo study identified an initial neural tube defect (NTD) safety signal with dolutegravir antiretroviral therapy (ART) exposure at conception. We conducted similar surveillance in 5 hospitals in Eswatini from September 2021 to September 2023 to evaluate the prevalence of birth defects and adverse pregnancy outcomes by maternal HIV status and ART regimen/timing. […]

The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) partners with ministries of health to design, develop, deploy, and maintain national health information ecosystems. A proven leader in the fight to end HIV and AIDS, EGPAF’s experience shows that digital health solutions—and the strategic data we’re able to capture and leverage—will be key to reaching and sustaining […]

Background: We assessed clinical outcomes among children, adolescents, and people younger than 25 years on darunavir-based antiretroviral therapy (ART) in 9 sub-Saharan African countries. Setting: Third-line ART centers in Cameroon, Eswatini, Kenya, Lesotho, Nigeria, Rwanda, Uganda, Zambia, and Zimbabwe. Methods: From January 2019 to December 2022, we collected data from a cohort of children, adolescents, and young people […]